NIPH Clinical Trials Search


Clinical TrialsSearch results


Number of results: 216
  • Recruitment status
  • Title of the study
  • Health Condition
  • Primary sponsor
  • Date of registration
  • Recruiting

  • Corona VIrus Disease 2019
  • Kinjo Takeshi
  • 2021-01-07
  • Recruiting

  • INTEGRAL study
  • Diffuse/tandem Coronary Lesions
  • Matsuo Hitoshi
  • 2020-08-24
  • Other

  • PROUD48
  • Dyslipidemic patients
  • Takeda Yasutaka
  • 2020-04-28
  • Recruiting

  • Multi-center observational study and present status survey for the establishment of the standard method for the long-term use of HAL.
  • The subjects will consist of patients with reduced walking function due to slowly progressive neurological/muscular diseases. HAL for medical use (lower limb type) is indicated for the following slowly progressive neurological/muscular diseases:spinal muscular atrophy (SMA), spinal and bulbar muscular atrophy (SBMA), amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), distal myopathy, inclusion body myositis (IBM), congenital myopathy, and muscular dystrophy. Patients who were diagnosed with one of the 8 diseases and require walking assistance or aids will be included as subjects. In addition, even patients who were not definitively diagnosed with one of the above 8 diseases but use HAL in daily medical practice at the attending physician's discretion will be included as subjects.
  • Takashi Nakajima
  • 2019-08-02

Progress situation

The subject of age and gender